Wednesday, February 5, 2025
There was great news this week about the novel coronavirus vaccine being developed by Pfizer (PFE) and Germany’s BioNTech (BNTX). The vaccine has been found to be more than 90% effective, and, if approved, it will be the first vaccine ever that uses novel mRNA technology. These results (although early and not independently vetted) far […]
It is an exciting time to be an income-focused investor. Business results are improving, yet share prices have not recovered from the February-March crash. The lack of share price recovery allows us to pick up shares of solid income stocks at excellent yields. Who wouldn’t like earning 9%, 11%, or even 15% from an investment […]
There’s a whole lot to unpack from last week. After five days of waiting for definitive numbers, media outlets have called the presidential election for Joe Biden. Senate control may take until January to decide due to two runoffs in Georgia. In other words, the market has plenty to digest. Before we talk about trading […]
Fate Therapeutics (FATE) is one of the hottest biotech stocks of the year. Since 2020, FATE ran from a low of $18.80 to a recent high of $48.20, good for a return of 156%, as compared to the iShares Nasdaq Biotech ETF (IBB), which is up 16%. From here, FATE could see higher highs ahead […]
While most eyes were on the US election, Chinese electric vehicle maker Nio (NIO) is off to the races. NIO’s stock price has climbed over 37% this past week and is up a whopping 838% for the year. The company recently announced strong October sales and better than expected growth. At least one analyst expects […]
There is frustration among numerous management teams of companies with high-dividend yields that the stock market has not credited for continued dividend payments. The result has been stock prices that fell and stayed down, resulting in tremendously high yields on the shares. I admire the companies that have protected their investors by not cutting dividends; […]
For the past few months we’ve been doing quite a bit of work on how to play a pending infrastructure bill. We’ve finally now narrowed down our positions to a few stocks, mainly etf’s. Today we’ll review these with a bit of a glimpse through the lens of charts.
It was just last week when I told you that Intel’s deal to sell its loss-making NAND flash memory unit was the beginning of a move toward greater consolidation in the semiconductor industry. And sure enough, a few days later, another major deal was announced. This time Advanced Micro Devices (AMD) agreed to buy rival […]
Gig economy stocks, like LYFT Inc. (LYFT) and Uber (UBER) got a boost earlier this week on the passage of California Prop 22 won. As noted by The Guardian, LYFT and UBER won a major victory to classify drivers as contractors, not employees following the passage of the measure. “The passage of proposition 22 in […]
Finally, election day is in the books. No more calls, texts, or TV ads, and soon congress and the president can get back to governing the country. Even if your guy was not the winner, do not despair about your investment prospects. History shows that the U.S. stock market has gone up during the term(s) […]
